CLVSQ's logo.
Ticker Symbol: CLVSQ

Clovis Oncology Inc

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0001466301

Company Profile

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 5500 Flatiron Pkwy Unit 100
CEO: Patrick Mahaffy
Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.00 ( 45.63%)
Days Range: $0.01 - $0.01
Beta: -
52wk. High: $0.18
52wk. Low: $0.01
Ytd. Change -34.86%
50 Day Moving Average: $0.02
200 Day Moving Average: $0.06
Shares Outstanding: 145487050

Valuation

Market Cap: 218.2M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A